Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 18,022,602 | reported | 29 Mar 2022 | tx 9+21,187,722 |
| Personalis, Inc. | 3,753,340 | reported | 20 Oct 2020 | tx 14+5,260,651−6,956,605 |
| Vera Therapeutics, Inc. | 2,960,403 | reported | 17 Aug 2022 | tx 8+2,980,081−19,850 |
| CHIASMA, INC | 2,600,741 | reported | 15 Jul 2015 | tx 10+4,681,336−5,201,482 |
| Sientra, Inc. | 2,480,494 | reported | 07 May 2018 | tx 2+776,482 |
| Protara Therapeutics, Inc. | 2,144,517 | reported | 12 Nov 2019 | tx 11+2,179,741−28,879,471 |
| AMARIN CORP PLC\UK | 1,599,168 | reported | 19 Apr 2012 | tx 15+11,683−19,420,856 |
| ProNAi Therapeutics Inc | 1,314,127 | reported | 31 Jan 2022 | tx 3+437,471−287,471 |
| Jasper Therapeutics, Inc. | 1,066,189 | reported | 08 Feb 2024 | tx 2+268,045 |
| Vaxcyte, Inc. | 40,000 | reported | 11 Jun 2020 | tx 2+40,000−40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Feb 2024 | PURCHASE | Jasper Therapeutics, Inc. | 190,000 | 12.95 USD | first after silence |
| 17 Aug 2022 | EXERCISE | Vera Therapeutics, Inc. | 9,925 | 11.00 USD | |
| 17 Aug 2022 | SALE | Vera Therapeutics, Inc. | 3,281 | 19.88 USD | |
| 17 Aug 2022 | SALE | Vera Therapeutics, Inc. | 6,472 | 20.42 USD | |
| 17 Aug 2022 | SALE | Vera Therapeutics, Inc. | 172 | 21.07 USD | anomaly |
| 17 Aug 2022 | EXERCISE | Vera Therapeutics, Inc. | 9,925 | 0.00 USD | deriv |
| 29 Mar 2022 | PURCHASE | SOLENO THERAPEUTICS INC | 7,720,000 | — | |
| 21 Dec 2018 | GRANT_AWARD | SOLENO THERAPEUTICS INC | 20,000 | 0.00 USD | deriv |
| 29 Mar 2022 | PURCHASE | SOLENO THERAPEUTICS INC | 7,720,000 | — | deriv |
| 18 May 2020 | GRANT_AWARD | SOLENO THERAPEUTICS INC | 9,530 | 0.00 USD | deriv |
| 08 Jan 2021 | GRANT_AWARD | SOLENO THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 10 Jun 2019 | GRANT_AWARD | SOLENO THERAPEUTICS INC | 13,000 | 0.00 USD | deriv |
| 01 Jun 2021 | GRANT_AWARD | SOLENO THERAPEUTICS INC | 31,862 | 0.00 USD | deriv |
| 21 Mar 2022 | GRANT_AWARD | Jasper Therapeutics, Inc. | 78,045 | 0.00 USD | deriv |
| 28 Jan 2022 | EXERCISE | ProNAi Therapeutics Inc | 287,471 | 13.20 USD | |
| 31 Jan 2022 | PURCHASE | ProNAi Therapeutics Inc | 150,000 | 27.00 USD | |
| 28 Jan 2022 | EXERCISE | ProNAi Therapeutics Inc | 287,471 | 0.00 USD | deriv |
| 06 Oct 2021 | GRANT_AWARD | Locust Walk Acquisition Corp. | 40,000 | 0.00 USD | deriv |
| 18 May 2021 | PURCHASE | Vera Therapeutics, Inc. | 772,727 | 11.00 USD | |
| 18 May 2021 | CONVERSION | Vera Therapeutics, Inc. | 2,187,504 | — | |
| 13 May 2021 | GRANT_AWARD | Vera Therapeutics, Inc. | 9,925 | 0.00 USD | deriv |
| 20 Oct 2020 | SALE | Personalis, Inc. | 130,486 | 27.66 USD | |
| 19 Oct 2020 | SALE | Personalis, Inc. | 196,423 | 27.86 USD | |
| 16 Oct 2020 | SALE | Personalis, Inc. | 94,218 | 26.68 USD | |
| 14 Oct 2020 | SALE | Personalis, Inc. | 81,925 | 27.08 USD |
3 purchases reported after at least 12 months of silence — most recent on 08 Feb 2024.